CDKN2A and astrocytoma (excluding glioblastoma): Moreover, these studies may inadvertently provide a mechanistic endorsement of upgrading to CNS WHO grade 4 of IDH-mutant astrocytoma harboring CDKN2A/B homozygous deletion.